European Neuropsychopharmacology
Volume 20, Issue 12 , Pages 895-906 , December 2010

Periadolescent exposure to cannabinoids alters the striatal and hippocampal dopaminergic system in the adult rat brain

Received 9 March 2010 ,Revised 14 June 2010 ,Accepted 24 June 2010.

References 

  1. Anderson SM, Pierce RC. Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharmacol. Ther. 2005;106:389–403
  2. Anthony JC. Death of the ‘stepping-stone’ hypothesis and the ‘gateway’ model? Comments on Morral et al. Addiction. 2002;97:1505–1507
  3. Arnold JC. The role of endocannabinoid transmission in cocaine addiction. Pharmacol. Biochem. Behav. 2005;81:396–406
  4. Becker JB, Hu M. Sex differences in drug abuse. Front. Neuroendocrinol. 2008;29:36–47
  5. Beltramo M, Bernardini N, Bertorelli R, Campanella M, Nicolussi E, Fredduzzi S, et al. CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms. Eur. J. Neurosci. 2006;23:1530–1538
  6. Ben-Shahar O, Moscarello JM, Ettenberg A. One hour, but not six hours, of daily access to self-administered cocaine results in elevated levels of the dopamine transporter. Brain Res. 2006;1095:148–153
  7. Ben-Shahar O, Keeley P, Cook M, Brake W, Joyce M, Nyffeler M, et al. Changes in levels of D1, D2, or NMDA receptors during withdrawal from brief or extended daily access to IV cocaine. Brain Res. 2007;1131:220–228
  8. Biscaia M, Fernandez B, Higuera-Matas A, Miguens M, Viveros MP, Garcia-Lecumberri C, et al. Sex-dependent effects of periadolescent exposure to the cannabinoid agonist CP-55, 940 on morphine self-administration behaviour and the endogenous opioid system. Neuropharmacology. 2008;54:863–873
  9. Black YD, Green-Jordan K, Eichenbaum HB, Kantak KM. Hippocampal memory system function and the regulation of cocaine self-administration behavior in rats. Behav. Brain Res. 2004;151:225–238
  10. Bossong MG, van Berckel BN, Boellaard R, Zuurman L, Schuit RC, Windhorst AD, et al. Delta9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology. 2009;34(3):759–766
  11. Britton DR, Curzon P, Mackenzie RG, Kebabian JW, Williams JE, Kerkman D. Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration. Pharmacol. Biochem. Behav. 1991;39:911–915
  12. Chao J, Nestler EJ. Molecular neurobiology of drug addiction. Annu. Rev. Med. 2004;55:113–132
  13. Cheer JF, Wassum KM, Sombers LA, Heien ML, Ariansen JL, Aragona BJ, et al. Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J. Neurosci. 2007;27:791–795
  14. Craft RM. Sex differences in behavioral effects of cannabinoids. Life Sci. 2005;77:2471–2478
  15. del Olmo N, Miguens M, Higuera-Matas A, Torres I, Garcia-Lecumberri C, Solis JM, et al. Enhancement of hippocampal long-term potentiation induced by cocaine self-administration is maintained during the extinction of this behavior. Brain Res. 2006;1116:120–126
  16. Del Olmo N, Higuera-Matas A, Miguens M, Garcia-Lecumberri C, Ambrosio E. Cocaine self-administration improves performance in a highly demanding water maze task. Psychopharmacology (Berlin). 2007;195(1):19–25
  17. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A. 1988;85:5274–5278
  18. Ellgren M, Spano SM, Hurd YL. Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology. 2007;32:607–615
  19. Farfel GM, Kleven MS, Woolverton WL, Seiden LS, Perry BD. Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey. Brain Res. 1992;578:235–243
  20. Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction. 2006;101:556–569
  21. Ferrer B, Gorriti MA, Palomino A, Gornemann I, de Diego Y, Bermudez-Silva FJ, et al. Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies. Eur. J. Pharmacol. 2007;559:180–183
  22. Frey U, Hartmann S, Matthies H. Domperidone, an inhibitor of the D2-receptor, blocks a late phase of an electrically induced long-term potentiation in the CA1-region in rats. Biomed. Biochim. Acta. 1989;48:473–476
  23. Garcia-Gil L, Ramos JA, Rubino T, Parolaro D, Fernandez-Ruiz JJ. Perinatal delta9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats. Neurotoxicol. Teratol. 1998;20:549–553
  24. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ, et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 1990;250:1429–1432
  25. Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, et al. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 2006;1071:10–23
  26. Gonzalez S, Bisogno T, Wenger T, Manzanares J, Milone A, Berrendero F, et al. Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland. Biochem. Biophys. Res. Commun. 2000;270:260–266
  27. Hall WD, Lynskey M. Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug Alcohol Rev. 2005;24:39–48
  28. Hall FS, Sora I, Drgonova J, Li XF, Goeb M, Uhl GR. Molecular mechanisms underlying the rewarding effects of cocaine. Ann. NY Acad. Sci. 2004;1025:47–56
  29. Higuera-Matas A, Soto-Montenegro ML, del Olmo N, Miguens M, Torres I, Vaquero JJ, et al. Augmented acquisition of cocaine self-administration and altered brain glucose metabolism in adult female but not male rats exposed to a cannabinoid agonist during adolescence. Neuropsychopharmacology. 2008;33:806–813
  30. Higuera-Matas A, Botreau F, Miguens M, Del Olmo N, Borcel E, Perez-Alvarez L, et al. Chronic periadolescent cannabinoid treatment enhances adult hippocampal PSA-NCAM expression in male Wistar rats but only has marginal effects on anxiety, learning and memory. Pharmacol. Biochem. Behav. 2009;93:482–490
  31. Howell DC. Statistical methods for psychology. 5th ed.. Pacific Grove, Calif: Duxbury Press; 2002;
  32. Ito R, Dalley JW, Robbins TW, Everitt BJ. Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J. Neurosci. 2002;22:6247–6253
  33. Kalivas PW, McFarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berlin). 2003;168:44–56
  34. Kandel DB, Yamaguchi K, Klein LC. Testing the gateway hypothesis. Addiction. 2006;101:470–472discussion 474-6
  35. Kantak KM, Goodrich CM, Uribe V. Influence of sex, estrous cycle, and drug-onset age on cocaine self-administration in rats (Rattus norvegicus). Exp. Clin. Psychopharmacol. 2007;15:37–47
  36. Letchworth SR, Nader MA, Smith HR, Friedman DP, Porrino LJ. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J. Neurosci. 2001;21:2799–2807
  37. Lynskey M. An alternative model is feasible, but the gateway hypothesis has not been invalidated: comments on Morral et al. Addiction. 2002;97:1505–1507
  38. Maldonado R, Valverde O, Berrendero F. Involvement of the endocannabinoid system in drug addiction. Trends Neurosci. 2006;29:225–232
  39. Manahan-Vaughan D, Kulla A. Regulation of depotentiation and long-term potentiation in the dentate gyrus of freely moving rats by dopamine D2-like receptors. Cereb. Cortex. 2003;13:123–135
  40. Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S. Dopamine transport function is elevated in cocaine users. J. Neurochem. 2002;81:292–300
  41. Masserano JM, Baker I, Natsukari N, Wyatt RJ. Chronic cocaine administration increases tyrosine hydroxylase activity in the ventral tegmental area through glutaminergic- and dopaminergic D2-receptor mechanisms. Neurosci. Lett. 1996;217:73–76
  42. McFarland K, Lapish CC, Kalivas PW. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J. Neurosci. 2003;23:3531–3537
  43. Meador-Woodruff JH, Little KY, Damask SP, Mansour A, Watson SJ. Effects of cocaine on dopamine receptor gene expression: a study in the postmortem human brain. Biol. Psychiatry. 1993;34:348–355
  44. Miguens M, Crespo JA, Del Olmo N, Higuera-Matas A, Montoya GL, Garcia-Lecumberri C, et al. Differential cocaine-induced modulation of glutamate and dopamine transporters after contingent and non-contingent administration. Neuropharmacology. 2008;55:771–779
  45. Moore RJ, Vinsant SL, Nader MA, Porrino LJ, Friedman DP. Effect of cocaine self-administration on dopamine D2 receptors in rhesus monkeys. Synapse. 1998;30:88–96
  46. Nader MA, Daunais JB, Moore T, Nader SH, Moore RJ, Smith HR, et al. Effects of cocaine self-administration on striatal dopamine systems in rhesus monkeys: initial and chronic exposure. Neuropsychopharmacology. 2002;27:35–46
  47. Orio L, Edwards S, George O, Parsons LH, Koob GF. A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions. J. Neurosci. 2009;29:4846–4857
  48. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 5 ed.. Burlington, Ma: Elsevier Academic Press; 2005;
  49. Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biol. Psychiatry. 2004;56:86–94
  50. Porrino LJ, Daunais JB, Smith HR, Nader MA. The expanding effects of cocaine: studies in a nonhuman primate model of cocaine self-administration. Neurosci. Biobehav. Rev. 2004;27:813–820
  51. Quinlan MG, Sharf R, Lee DY, Wise RA, Ranaldi R. Blockade of substantia nigra dopamine D1 receptors reduces intravenous cocaine reward in rats. Psychopharmacology (Berlin). 2004;175:53–59
  52. Rodriguez de Fonseca F, Ramos JA, Bonnin A, Fernandez-Ruiz JJ. Presence of cannabinoid binding sites in the brain from early postnatal ages. NeuroReport. 1993;4:135–138
  53. Rodriguez De Fonseca F, Gorriti MA, Bilbao A, Escuredo L, Garcia-Segura LM, Piomelli D, et al. Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson's disease and schizophrenia. Neurotox. Res. 2001;3:23–35
  54. Romero EM, Fernandez B, Sagredo O, Gomez N, Uriguen L, Guaza C, et al. Antinociceptive, behavioural and neuroendocrine effects of CP 55, 940 in young rats. Brain Res. Dev. Brain Res. 2002;136:85–92
  55. Ross RA, Coutts AA, McFarlane SM, Anavi-Goffer S, Irving AJ, Pertwee RG, et al. Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology. 2001;40:221–232
  56. Roth ME, Cosgrove KP, Carroll ME. Sex differences in the vulnerability to drug abuse: a review of preclinical studies. Neurosci. Biobehav. Rev. 2004;28:533–546
  57. Rowlett JK, Platt DM, Yao WD, Spealman RD. Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys. J. Pharmacol. Exp. Ther. 2007;321:1135–1143
  58. Rubino T, Realini N, Braida D, Guidi S, Capurro V, Vigano D, et al. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus. 2009;19:763–772
  59. Schneider M. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict. Biol. 2008;13:253–263
  60. Stander S, Schmelz M, Metze D, Luger T, Rukwied R. Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J. Dermatol. Sci. 2005;38:177–188
  61. Thompson AM, Swant J, Gosnell BA, Wagner JJ. Modulation of long-term potentiation in the rat hippocampus following cocaine self-administration. Neuroscience. 2004;127:177–185
  62. Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science. 2005;310:329–332
  63. Volkow ND, Gatley SJ, Fowler JS, Logan J, Fischman M, Gifford AN, et al. Cocaine doses equivalent to those abused by humans occupy most of the dopamine transporters. Synapse. 1996;24:399–402
  64. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Ding YS, Logan J, et al. Relationship between psychostimulant-induced “high” and dopamine transporter occupancy. Proc. Natl. Acad. Sci. U. S. A. 1996;93:10388–10392
  65. Vrana SL, Vrana KE, Koves TR, Smith JE, Dworkin SI. Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels. J. Neurochem. 1993;61:2262–2268
  66. Wada K. The concept of “gateway drug”. Nihon Arukoru Yakubutsu Igakkai Zasshi. 1999;34:95–106
  67. Wilson JM, Nobrega JN, Carroll ME, Niznik HB, Shannak K, Lac ST, et al. Heterogeneous subregional binding patterns of 3H-WIN 35, 428 and 3H-GBR 12, 935 are differentially regulated by chronic cocaine self-administration. J. Neurosci. 1994;14:2966–2979
  68. Wilson JM, Levey AI, Bergeron C, Kalasinsky K, Ang L, Peretti F, et al. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann. Neurol. 1996;40:428–439

PII: S0924-977X(10)00144-6

doi: 10.1016/j.euroneuro.2010.06.017

European Neuropsychopharmacology
Volume 20, Issue 12 , Pages 895-906 , December 2010

Article Tools

* Image Usage & Resolution